TY  - JOUR
AU  - Maurel, Joan
AU  - López-Pousa, Antonio
AU  - Calabuig, Silvia
AU  - Bagué, Silvia
AU  - Del Muro, Xavier Garcia
AU  - Sanjuan, Xavier
AU  - Rubió-Casadevall, Jordi
AU  - Cuatrecasas, Miriam
AU  - Martinez-Trufero, Javier
AU  - Horndler, Carlos
AU  - Fra, Joaquin
AU  - Valverde, Claudia
AU  - Redondo, Andrés
AU  - Poveda, Andrés
AU  - Sevilla, Isabel
AU  - Lainez, Nuria
AU  - Rubini, Michele
AU  - García-Albéniz, Xabier
AU  - Martín-Broto, Javier
AU  - de Alava, Enrique
PY  - 2016
DO  - 10.1186/s13569-016-0050-6
SN  - 2045-3329
UR  - https://hdl.handle.net/10668/27773
T2  - Clinical sarcoma research
AB  - Most GISTs have mutations in KIT or PDGFRA. Patients with advanced GIST with KIT exon 9, PDGFRA mutation or WT for KIT and PDGFRA have a worse progression-free survival (PFS) compared to patients with KIT exon 11 mutated tumors. We evaluated the...
LA  - en
TI  - Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study.
TY  - research article
VL  - 6
ER  -